Format

Send to

Choose Destination
Liver Int. 2017 Jan;37(1):111-120. doi: 10.1111/liv.13180. Epub 2016 Jul 5.

Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome.

Author information

1
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.
2
Imaging and Interventional Radiology Dept, Queen Elizabeth Hospital, Birmingham, UK.
3
Department of Radiology, National University Hospital, Singapore.
4
Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.

Abstract

BACKGROUND & AIMS:

A proportion of patients with Budd-Chiari Syndrome (BCS) associated with stenosis or short occlusion of the hepatic vein (HV) or upper inferior vena cava (IVC) can be treated with recanalization by percutaneous venoplasty ± HV stent insertion. We studied the long-term outcomes of this approach.

METHODS:

Single-centre retrospective analysis of patients referred for radiological assessment ± intervention over a 27-year period. Of 155 BCS patients, 63 patients who underwent venoplasty were studied and compared to a previously reported series treated by TIPSS (n = 59).

RESULTS:

Patients treated with HV interventions (32 venoplasty alone, 31 endovascular stents): mean age, 34.9 ± 10.9; M:F ratio 27:36; median follow-up, 113.0 months; 62% of patients had ≥1 haematological risk factor. Technical success was 100%, with symptom resolution in 73%. Cumulative secondary patency at 1, 5, 10 years was 92%, 79%, 79% and 69%, 69%, 64% in the stenting and venoplasty groups respectively. Where long-term patency was not achieved, 10 patients required TIPSS, and 8 underwent surgery. Actuarial survival at 1, 5, 10 years was 97%, 89% and 85%. When compared to TIPSS, HV interventions resulted in similar patency and survival rates but significantly lower procedural complications (9.5% vs 27.1%) and hepatic encephalopathy (0% vs 18%). Patient age predicted survival following multivariate analysis.

CONCLUSIONS:

Our data support the stepwise approach to management of BCS, with very good outcomes from venoplasty combined with stenting when required. TIPSS should only be offered where HV interventions are not feasible or unsuccessful.

KEYWORDS:

ascites; liver; portal hypertension; radiology/imaging

PMID:
27254473
DOI:
10.1111/liv.13180
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center